MeVis Medical Solutions AG (ETR:M3V)
Germany · Delayed Price · Currency is EUR 20.20
-1.40 (-6.48%)
Oct 26, 2026, 5:35 PM CET
ETR:M3V Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 37 | 45 | 42 | 52 | 62 | 59 | |
Market Cap Growth | -17.21% | 7.83% | -19.01% | -16.96% | 4.91% | 2.52% |
Enterprise Value | 33 | 43 | 37 | 47 | 58 | 55 |
Last Close Price | 21.60 | 23.90 | 21.37 | 25.36 | 29.72 | 27.51 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 26.56 | 14.26 | 9.18 | 10.51 | 7.99 | 13.05 |
Forward PE | - | 16.98 | 16.98 | 16.98 | 16.98 | 16.98 |
PS Ratio | 2.54 | 2.81 | 2.47 | 2.98 | 3.32 | 3.66 |
PB Ratio | 2.21 | 2.53 | 2.35 | 2.90 | 3.49 | 3.33 |
P/TBV Ratio | 2.21 | 2.53 | 2.35 | 2.90 | 3.49 | 3.33 |
P/FCF Ratio | 10.51 | 12.07 | 14.72 | 8.95 | 13.18 | 6.53 |
P/OCF Ratio | - | 11.64 | 13.30 | 8.83 | 12.81 | 6.50 |
PEG Ratio | - | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 2.30 | 2.65 | 2.18 | 2.73 | 3.09 | 3.41 |
EV/EBITDA Ratio | 44.49 | 17.26 | 8.95 | 9.53 | 8.83 | 10.75 |
EV/EBIT Ratio | 55.06 | 18.35 | 9.24 | 9.72 | 8.96 | 11.02 |
EV/FCF Ratio | 9.54 | 11.39 | 13.00 | 8.19 | 12.26 | 6.09 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Debt / Equity Ratio | -0.20 | -0.37 | -0.37 | -0.43 | -0.52 | -0.43 |
Net Debt / EBITDA Ratio | -4.55 | -2.64 | -1.58 | -1.56 | -1.42 | -1.48 |
Net Debt / FCF Ratio | - | -1.74 | -2.29 | -1.34 | -1.97 | -0.84 |
Asset Turnover | 0.66 | 0.61 | 0.62 | 0.59 | 0.64 | 0.59 |
Quick Ratio | 3.03 | 4.13 | 4.14 | 3.99 | 4.68 | 4.41 |
Current Ratio | 3.16 | 4.24 | 4.26 | 4.10 | 4.78 | 4.56 |
Return on Equity (ROE) | 7.77% | 17.76% | 25.59% | 27.60% | 43.70% | 25.50% |
Return on Assets (ROA) | 1.73% | 5.54% | 9.17% | 10.26% | 13.76% | 11.33% |
Return on Invested Capital (ROIC) | 4.28% | 19.82% | 36.43% | 51.15% | 68.35% | 40.90% |
Return on Capital Employed (ROCE) | 3.10% | 9.80% | 16.50% | 19.20% | 22.90% | 19.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | 3.77% | 7.01% | 10.90% | 9.52% | 12.51% | 7.66% |
FCF Yield | 9.51% | 8.28% | 6.79% | 11.17% | 7.59% | 15.30% |
Dividend Yield | 5.59% | 4.56% | 4.91% | 3.35% | - | - |
Total Shareholder Return | 5.28% | 4.56% | 4.91% | 3.35% | - | - |